[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- Sponsored Message [Why is Russia reopening dormant copper mines?](=) [Here's where to look]() --------------------------------------------------------------- December 5, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsored Message [Is Taiwan a Chinese Red Herring? The Real Threat to the U.S.]( =As tensions mount over Taiwan, China is engaging in a stealth war against the U.S. that could cripple our military production. China controls up to 90% of the critical elements needed to secure our national defense. But new mineral discoveries in America could end our dependence on China. One exploration company is well-positioned to advance U.S. national security interests. [Click here for this rare investment opportunity]() --------------------------------------------------------------- [Ehang Holdings, EH]() Recent Analyst Action: Allen Chang, analyst at Goldman Sachs, reiterates coverage on [Ehang Holdings (EH)](in the Technology sector with a Hold rating and a price target of $ 4 (1 month ago). - Recent Price: $7.19 - Average Analyst Price Target: $4.00 (-44.37%) - Market Cap: $328.02M [TipRanks.com]( also reports that [Ehang Holdings]()currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $4.00 . The target pricing ranges from a high forecast of $4.00 down to a low forecast of $4.00. [Ehang Holdings (EH)](’s last closing price was $7.19 which would put the average price target at $4.00. Here are 3rd party ratings for [EH](=): - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsored Message [Beat the crisis and reach financial goals 2X faster](=) =Hi, I'm Tim Melvin, and for 34 years, I've become the master at investing in a very narrow branch of the stock market. Undervalued dividend stocks. First, because they pay dividends and survived all the major crises in the last 90+ years. Second, because they're massively undervalued. Third, because no one knows about these stocks, so I'm buying these for peanuts. And because I want to help you survive this crisis, beat inflation and become immune to rising interest rates... I'm giving you 3 of my best picks ABSOLUTELY FREE. [Click here for their ticker symbols.](=) = --------------------------------------------------------------- [BioRestorative Therapies, BRTX]() Recent Analyst Action: Michael Okunewitch, analyst at Maxim Group, reiterates coverage on [BioRestorative Therapies (BRTX)](=)in the Healthcare sector with a Buy rating and a price target of $ 6 (2 months ago). - Recent Price: $3.85 - Average Analyst Price Target: $6.00 (55.84%) - Market Cap: $13.50M [TipRanks.com]( also reports that [BioRestorative Therapies](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.00 . The target pricing ranges from a high forecast of $6.00 down to a low forecast of $6.00. [BioRestorative Therapies (BRTX)](=)’s last closing price was $3.85 which would put the average price target at $6.00. Here are 3rd party ratings for [BRTX](): - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 20% (50 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- [GrowGeneration, GRWG]( Recent Analyst Action: Aaron Grey, analyst at Alliance Global Partners, reiterates coverage on [GrowGeneration (GRWG)]()in the Industrial Goods sector with a Hold rating and a price target of $ 4 (3 weeks ago). - Recent Price: $8.45 - Average Analyst Price Target: $4.00 (-52.66%) - Market Cap: $488.65M [TipRanks.com]( also reports that [GrowGeneration](=)currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $4.00 . The target pricing ranges from a high forecast of $4.00 down to a low forecast of $4.00. [GrowGeneration (GRWG)](’s last closing price was $8.45 which would put the average price target at $4.00. Here are 3rd party ratings for [GRWG](=): - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 37% (93 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsored Message [Jim Rickards: Make no mistake, C-Day will change your financial life forever...](=) =What is “C-Day”? It’s the day America goes cashless… And it could come as soon as Dec. 13, 2022. America’s top financial forecaster, Jim Rickards, has uncovered all the evidence of a new central bank digital currency… He got his hands on the executive orders issued by Joe Biden… the secretive plans of the Federal Reserve and other central bankers… and even the name of the company working on the new digital dollar. [Go here now to get all the details on “C-Day” from Jim Rickards.](=) = --------------------------------------------------------------- [Cabaletta Bio, CABA]() Recent Analyst Action: Douglas Tsao, analyst at H.C. Wainwright, reiterates coverage on [Cabaletta Bio (CABA)](in the Healthcare sector with a Buy rating and a price target of $ 11 (3 weeks ago). - Recent Price: $5.2 - Average Analyst Price Target: $9.25 (77.88%) - Market Cap: $143.33M [TipRanks.com]() also reports that [Cabaletta Bio](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $9.25 . The target pricing ranges from a high forecast of $12.00 down to a low forecast of $4.00. [Cabaletta Bio (CABA)](’s last closing price was $5.2 which would put the average price target at $9.25. Here are 3rd party ratings for [CABA](): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 20% (50 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Greentree Hospitality Group, GHG]() Recent Analyst Action: Simon Cheung, analyst at Goldman Sachs, reiterates coverage on [Greentree Hospitality Group (GHG)](in the Services sector with a Hold rating and a price target of $ 4.9 (2 months ago). - Recent Price: $3.51 - Average Analyst Price Target: $4.90 (39.60%) - Market Cap: $335.94M [TipRanks.com]( also reports that [Greentree Hospitality Group]()currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $4.90 . The target pricing ranges from a high forecast of $4.90 down to a low forecast of $4.90. [Greentree Hospitality Group (GHG)](’s last closing price was $3.51 which would put the average price target at $4.90. Here are 3rd party ratings for [GHG](): - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Top 37% (93 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsored Message [Mover Over Lithium - 220 Pounds of Graphite In Every EV Battery]() Investors constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska. [See Why Investors Are So Excited About This New Mineral Claim Discovery]() = --------------------------------------------------------------- [Iovance Biotherapeutics, IOVA]() Recent Analyst Action: Reni Benjamin, analyst at JMP Securities, reiterates coverage on [Iovance Biotherapeutics (IOVA)](=)in the Healthcare sector with a Buy rating and a price target of $ 21 (2 weeks ago). - Recent Price: $8.2 - Average Analyst Price Target: $24.38 (197.32%) - Market Cap: $1.08B [TipRanks.com]( also reports that [Iovance Biotherapeutics](=)currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $24.38 . The target pricing ranges from a high forecast of $38.00 down to a low forecast of $11.00. [Iovance Biotherapeutics (IOVA)](=)’s last closing price was $8.2 which would put the average price target at $24.38. Here are 3rd party ratings for [IOVA](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 20% (50 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- [Tilray, TLRY]() Recent Analyst Action: Nadine Sarwat, analyst at Bernstein, reiterates coverage on [Tilray (TLRY)]()in the Basic Materials sector with a Hold rating and a price target of $ 3.9 (1 month ago). - Recent Price: $5.02 - Average Analyst Price Target: $4.36 (-13.15%) - Market Cap: $2.80B [TipRanks.com]( also reports that [Tilray](currently has 9 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $4.36 . The target pricing ranges from a high forecast of $9.00 down to a low forecast of $2.00. [Tilray (TLRY)]()’s last closing price was $5.02 which would put the average price target at $4.36. Here are 3rd party ratings for [TLRY](): - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 22% (196 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsored Message [U.S. and China Locked in an all-out Resource War!]() The winner will control the 21st Century. The U.S. MUST find NEW domestic sources of critical minerals, such as cobalt, lithium and rare earths needed to ensure superiority in our military and mobile and green technologies. One exploration company is determined to help with potential big discoveries in Idaho, Montana and Nevada. [Click here for this urgent investment opportunity]() --------------------------------------------------------------- And there you have it--7 Micro Cap Stocks that are getting attention from some of Wall Street Top Analysts. Sincerely, The Editor, marketsectordaily.com [Unsubscribe]() Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States (877) 411-9808